Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Late-Breaking SWEDEPAD Trial Finds No Benefit of Drug-Coated Balloons and Stents, Raises Safety Concerns
Mårten Falkenberg/ Vascular News
Aug 31, 2025, 07:12

Late-Breaking SWEDEPAD Trial Finds No Benefit of Drug-Coated Balloons and Stents, Raises Safety Concerns

Vascular News shared an important post on LinkedIn:

“BREAKING NEWS: Drug-coated balloons and stents were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in the SWEDEPAD 1 and 2 trials. In addition, higher five-year mortality with drug-coated devices in patients with intermittent claudication was noted, leading researchers to stress that the safety of paclitaxel-coated devices is an “ongoing discussion”.

These late-breaking findings were presented today at the European Society of Cardiology (ESC) 2025 congress (29 August–1 September, Madrid, Spain) and simultaneously published in The Lancet Group.”

Read more here.

Stay updated with Hemostasis Today.

Cardiovascular Science Drug Coated Balloons Drug Coated Stents endovascular therapy ESC 2025 Five Year Mortality Health Hematology Hemostasis Today Intermittent Claudication Medicine Paclitaxel Peripheral Artery Disease Quality of Life SWEDEPAD Trials The Lancet Vascular Research
NewsFeed